Studie

An international prospective study on clinically standard-risk medulloblastoma in children older than 3 to 5 years with low-risk biological profile (PNET 5 MB - LR) or average-risk biological profile (PNET 5 MB - SR)

Erkrankungsgruppe:

Solide Tumore, ZNS und Gehirntumore

Organsystem:

Gehirn

Stadium:

Ersterkrankung

Standort:

Dortmund, Bonn, Essen, Homburg/ Saar, Universitätsklinikum Köln, Helios Klinikum Krefeld

EudraCT:

2011-004868-30

Prüfplan-Code:

SIOP PNET 5 MB

Phase:

II/III

Prüfsubstanz:

Carboplatin, Cisplatin, Lomustine, Vincristine Sulfate, Cyclophosphamide Monohydrate

Sponsor:

Universitätsklinikum Hamburg-Eppendorf